References
- Benowitz, N.L., Jacob, P., and Savanapridi, C., 1987. Determinants of nicotine intake while chewing nicotine polacrilex gum. Clinical Pharmacology and Therapeutics, 41 (4), 467–473.
- Bishop, E., et al., 2020. An approach for the extract generation and toxicological assessment of tobacco-free 'modern' oral nicotine pouches. Food and Chemical Toxicology, 145, 111713. doi: 10.1016/j.fct.2020.111713.
- Burns, D.M., et al., 2008. Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tobacco Control, 17 (2), 132–141.
- Caraway, J.W., and Chen, P.X., 2013. Assessment of mouth-level exposure to tobacco constituents in U.S. snus consumers. Nicotine & Tobacco Research, 15 (3), 670–677.
- Clarke, E., et al., 2019. Snus: a compelling harm reduction alternative to cigarettes. Harm Reduction Journal, 16 (1), 62.
- Cuello-Nuñez, S., et al., 2018. Fractionation of cadmium in tobacco and cigarette smoke condensate using XANES and sequential leaching with ICP-MS/MS. Analytical and Bioanalytical Chemistry, 410 (26), 6795–6806.
- Digard, H., et al., 2013a. Determination of nicotine absorption from multiple tobacco products and nicotine gum. Nicotine & Tobacco Research, 15 (1), 255–261.
- Digard, H., et al., 2013b. Multi-analyte approach for determining the extraction of tobacco constituents from pouched snus by consumers during use. Chemistry Central Journal, 7 (1), 55.
- European Commission, 2017. Special Eurobarometer 458. Attitudes of Europeans towards tobacco and electronic cigarettes. Available from: https://ec.europa.eu/commfrontoffice/publicopinion/index.cfm/ResultDoc/download/DocumentKy/79003 [Accessed 30 October 2020].
- Electronic Medicines Compendium (EMC), 2020. SmPc Nicorette Cools 4mg lozenge. Available from: https://www.medicines.org.uk/emc/product/4114/smpc [Accessed 17 November 2020].
- European Union (EU), 2009. Commission Regulation (EC) No 1170/2009 of 30 November 2009. Official Journal of the European Union. Available from: https://www.fsai.ie/uploadedFiles/Reg1170_2009.pdf [Accessed 30 October 2020].
- Fagerstrom, K.A., 2018. Comparison of dependence across different types of nicotine containing products and coffee. International Journal of Environmental Research and Public Health, 15 (8), 1609.
- Ferlay, J., et al., 2013. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer (Oxford, England : 1990), 49 (6), 1374–1403.
- Gartner, C.E., et al., 2007. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet (London, England), 369 (9578), 2010–2014.
- Gottlieb, S., 2017. Protecting American families: Comprehensive approach to nicotine and tobacco. Speech by Scott Gottlieb, FDA, White Oak, MD. Available from: https://www.fda.gov/news-events/speeches-fda-officials/protecting-american-families-comprehensive-approach-nicotine-and-tobacco-06282017 [Accessed 30 October 2020].
- Hansson, A., et al., 2019. Effect of nicotine 6 mg gum on urges to smoke, a randomized clinical trial. BMC Pharmacology and Toxicology, 20 (1), 69. https://doi.org/10.1186/s40360-019-0368-9
- Health Products Regulatory Authority (HPRA), 2020. PIL Nicorette medicated chewing gum. Available from: https://www.hpra.ie/img/uploaded/swedocuments/7c975abd-331a-4158-a0d3-b5fadbd9f2f9.pdf [Accessed 05 January 2021].
- Kondratieva, K., 2020. Russian Duma passes bill banning tobacco-free white pouches [online]. Tobacco intelligence. Available from: https://tobaccointelligence.com/russia-gives-green-light-to-ban-tobacco-free-white-pouches/ [Accessed 27 April 2021].
- Lawler, T.S., et al., 2020. Chemical analysis of snus products from the United States and northern Europe. PLoS One, 15 (1), e0227837.
- Lee, P.N., 2011. Summary of the epidemiological evidence relating snus to health. Regulatory Toxicology and Pharmacology, 59 (2), 197–214.
- Lee, P.N., and Fariss, M.W., 2017. A systematic review of possible serious adverse health effects of nicotine replacement therapy. Archives of Toxicology, 91 (4), 1565–1594.
- Le Houezec, J., 2003. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. The International Journal of Tuberculosis and Lung Disease, 7 (9), 811–819.
- Lunell, E., and Lunell, M., 2005a. Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: A crossover study. Nicotine & Tobacco Research, 7 (3), 397–403.
- Lunell, E., and Lunell, M., 2005b. In-vivo extraction of lead, cadmium and tobacco specific nitrosamines from four brands of Swedish snus in regular snus users [abstract]. Presented at 11th Annual Meeting and 7th Annual European Conference of the Society for Research on Nicotine and Tobacco, Prague, Czech Republic, March 20–23, 2005; Rapid Communications Poster Abstract RP-076. https://cdn.ymaws.com/srnt.site-ym.com/resource/resmgr/Conferences/Past_Annual_Meetings/2005_Annual_Meeting_Abstract.pdf [Accessed 18 November 2020].
- Lunell, E., and Curvall, M., 2011. Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum. Nicotine & Tobacco Research, 13 (7), 573–578.
- Lunell, E., et al., 2020. Pharmacokinetic comparison of a novel non-tobacco-based nicotine pouch (ZYN) with conventional, tobacco-based Swedish snus and American moist snuff. Nicotine & Tobacco Research, 22 (10), 1757–1763. doi: 10.1093/ntr/ntaa068.
- Margham, J., et al., 2016. Chemical composition of aerosol from an e-cigarette: a quantitative comparison with cigarette smoke. Chemical Research in Toxicology, 29 (10), 1662–1678.
- McAdam, K.G., et al., 2013. Polycyclic aromatic hydrocarbons in US and Swedish smokeless tobacco products. Chemistry Central Journal, 7, 151.
- McAdam, K., et al., 2015. The acrylamide content of smokeless tobacco products. Chemistry Central Journal, 9, 56.
- McAdam, K., et al., 2018. Ethyl carbamate in Swedish and American smokeless tobacco products and some factors affecting its concentration. Chemistry Central Journal, 12 (1), 86.
- McAdam, K.G., et al., 2019. The composition of contemporary American and Swedish smokeless tobacco products. BMC Chemistry, 13 (1), 31.
- McNeill, A., and Munafò, M.R., 2013. Reducing harm from tobacco use. Journal of Psychopharmacology, 27 (1), 13–18.
- Nessa, F., Khan, S.A., and Abu Shawish, K.Y., 2016. Lead, cadmium and nickel contents of some medicinal agents. Indian Journal of Pharmaceutical Sciences, 78 (1), 111–119. https://doi.org/10.4103/0250-474X.180260.
- Nutt, D.J., et al., 2014. Estimating the harms of nicotine-containing products using the MCDA approach. European Addiction Research, 20 (5), 218–225.
- Proctor, C., Patwardhan, S., Murphy, J., 2017. A model risk continuum for tobacco and nicotine products. Washington, DC: Food and Drug Law Institute. Available from: https://www.fdli.org/2017/08/spotlight-tobacco-model-risk-continuum-tobacco-nicotine-products/ [Accessed 30 October 2020].
- Public Health England (PHE), 2019. Health matters: stopping smoking - what works? London: Public Health England. Available from: https://www.gov.uk/government/publications/health-matters-stopping-smoking-what-works/health-matters-stopping-smoking-what-works [Accessed 30 October 2020].
- Ramboll, 2019. Systematic review and update of the literature on the health effects of Swedish snus. Arlington, VA: Ramboll. Available from: https://www.swedishmatch.com/globalassets/documents/other/ramboll-health-effects-update-report_20190513.pdf [Accessed 30 October 2020].
- Restani, P., and Galli, C.L., 1991. Oral toxicity of formaldehyde and its derivatives. Critical Reviews in Toxicology, 21 (5), 315–328.
- Royal College of Physicians (RCP), 2007. Harm reduction in nicotine addiction: Helping people who can’t quit. London, UK: Royal College of Physicians. Available from: https://shop.rcplondon.ac.uk/collections/books-1 [Accessed 30 October 2020].
- Royal College of Physicians (RCP), 2016. Nicotine with smoke: Tobacco harm reduction. London: RCP. Available from: https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction [Accessed 30 October 2020].
- Schep, L.J., Slaughter, R.J., and Beasley, M.G., 2009. Nicotinic plant poisoning. Clinical Toxicology (Philadelphia, Pa.), 47 (8), 771–781.
- Schneider, N.G., et al., 2001. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clinical Pharmacokinetics, 40 (9), 661–684.
- Song, M.A., et al., 2016. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products. Toxicology Letters, 245, 68–77.
- Stepanov, I., et al., 2006. Tobacco-specific nitrosamines in new tobacco products. Nicotine & Tobacco Research, 8 (2), 309–313.
- Stratton, K., Shetty, P., Wallace, R., and Bondurant, S., eds., 2001. Clearing the smoke: assessing the science base for tobacco harm reduction. Washington, DC: National Academy Press.
- Swedish Food Agency, 2016. The National Food Administration’s regulations on snus and chewing tobacco [in Swedish]. Available from: https://www.livsmedelsverket.se/om-oss/lagstiftning1/gallande-lagstiftning/livsfs-20126 [Accessed 30 October 2020].
- Swedish Match, 2016. GothiaTek® limits for undesired components. Stockholm: Swedish Match. Available from https://www.swedishmatch.com/Snus-and-health/GOTHIATEK/GOTHIATEK-standard/ [Accessed 30 October 2020].
- Swedish Match, 2020. The Swedish experience. Stockholm, Sweden: Swedish Match. Available from: https://www.swedishmatch.com/Snus-and-health/The-Swedish-experience/ [Accessed 30 October 2020].
- US Department of Health and Human Services (DHHS), 2014. The health consequences of smoking–50 years of progress: A report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention. Available from: https://www.hhs.gov/surgeongeneral/reports-and-publications/tobacco/index.html [Accessed 30 October 2020].
- US Food and Drug Administration (FDA), 2012. Reporting harmful and potentially harmful constituents in tobacco products and tobacco smoke under section 904(a)(3) of the Federal Food, Drug, and Cosmetic Act. Atlanta: FDA. Available from https://www.fda.gov/regulatory-information/search-fda-guidance-documents/reporting-harmful-and-potentially-harmful-constituents-tobacco-products-and-tobacco-smoke-under [Accessed 30 October 2020].
- US Food and Drug Administration (FDA), 2019. Generally recognized as safe. Silver Spring, MD: FDA. Available from: https://www.fda.gov/food/food-ingredients-packaging/generally-recognized-safe-gras [Accessed 30 October 2020].
- US National Institutes of Health (NIH), 2020. Chromium dietary supplement fact sheet. Atlanta: US Department of Health & Human Services. Available from: https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/#en12 [Accessed 30 October 2020].
- US Pharmacopeia (USP), n.d. Nicotine. Available from: http://www.pharmacopeia.cn/v29240/usp29nf24s0_m56620.html [Accessed 12 November 2020].
- World Health Organization (WHO), 2001. Formaldehyde. Geneva: WHO. Available from: http://www.euro.who.int/__data/assets/pdf_file/0014/123062/AQG2ndEd_5_8Formaldehyde.pdf [Accessed 30 October 2020].
- World Health Organization (WHO), 2019. European tobacco use: Trends report. Geneva: WHO. Available from: http://www.euro.who.int/__data/assets/pdf_file/0009/402777/Tobacco-Trends-Report-ENG-WEB.pdf?ua=1 [Accessed 14 April 2020].